INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol QLINE
MSEI Symbol NOTLISTED
ISIN INEIG2W01011
Name of Company Q-Line Biotech Limited
Type of company SME
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 17-06-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 12-06-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 17-06-2026   15:30:00
End date and time of board meeting 17-06-2026   18:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion


Financial Results — Other than Bank

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Revenue From Operations
Revenue from operations 19,793.76 34,173.57
Other income 303.04 570.34
Total Income 20,096.80 34,743.91
2 Expenses
(a) Cost of materials consumed 4,872.20 7,971.63
(b) Purchases of stock-in-trade 2,600.28 5,776.11
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (138.15) (337.00)
(d) Employee benefit expense 2,406.47 4,005.09
(e) Finance costs 1,111.02 1,941.68
(f) Depreciation and amortisation expense 670.29 1,079.06
(g) Other Expenses
1 other expenses 3,845.12 6,953.21
Total other expenses 3,845.12 6,953.21
Total expenses 15,367.23 27,389.78
3 Profit before exceptional and extraordinary items and tax 4,729.57 7,354.13
4 Exceptional items 0.00 0.00
5 Profit before extraordinary items and tax 4,729.57 7,354.13
6 Extraordinary items (99.17) (99.17)
7 Profit before tax 4,630.40 7,254.96
8 Tax Expense
Current tax 1,210.74 1,691.04
Deferred tax (20.89) (8.24)
Total tax expenses 1,189.85 1,682.80
9 Net Profit Loss for the period from continuing operations 3,440.55 5,572.16
10 Profit (loss) from discontinuing operations before tax 0.00 0.00
11 Tax expense of discontinuing operations 0.00 0.00
12 Net profit (loss) from discontinuing operation after tax 0.00 0.00
13 Profit (loss) for period before minority interest 3,440.55 5,572.16
14 Share of profit (loss) of associates 0.00 0.00
15 Profit (loss) of minority interest 0.00 0.00
16 Net profit (Loss) for the period 3,440.55 5,572.16
17 Details of equity share capital
Paid-up equity share capital 1,627.50 1,627.50
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 22,991.70
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 21.48 34.79
Diluted earnings (loss) per share from continuing and discontinued operations 21.48 34.79
20 Debt equity ratio 0.9200 0.9200
21 Debt service coverage ratio 1.1100 1.1600
22 Interest service coverage ratio 8.2800 5.00
23 Disclosure of notes on financial results


Remarks

20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect

Amount in (Lakhs)

A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 7,354.13
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 1,941.68
Adjustments for depreciation and amortisation expense 1,079.06
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for unrealised foreign exchange losses gains 313.63
Adjustments for dividend income 0.00
Adjustments for share-based payments 0.00
Other adjustments for which cash effects are investing or financing cash flow (13.08)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 200.48
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments to profit (loss) 3,521.77
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories (474.65)
Adjustments for decrease (increase) in trade receivables (4,375.18)
Adjustments for decrease (increase) in other current assets (312.78)
Adjustments for increase (decrease) in trade payables (627.97)
Adjustments for increase (decrease) in other current liabilities (190.82)
Adjustments for provisions (88.55)
Total adjustments for working capital (6,069.95)
Total adjustments for reconcile profit (loss) (2,548.18)
Net cash flows from (used in) operations 4,805.95
Dividends received 0.00
Interest paid 0.00
Interest received (466.50)
Income taxes paid (refund) 2,602.73
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities before extraordinary items 1,736.72
Proceeds from extraordinary items 0.00
Payment for extraordinary items 99.17
Net cash flows from (used in) operating activities 1,637.55
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property plant and equipment 48.66
Purchase of property plant and equipment 3,591.37
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 466.50
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 134.60
Proceeds from government grants 0.00
Net cash flows from (used in) investing activities before extraordinary items (2,941.61)
Proceeds from extraordinary items 0.00
Payment for extraordinary items 0.00
Net cash flows from (used in) investing activities (2,941.61)
Cash flows from used in financing activities
Proceeds from issuing shares 52.50
Proceeds from issuing other equity instruments 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 6,053.31
Repayments of borrowings 0.00
Dividends paid 0.00
Interest paid 1,941.67
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities before extraordinary items 4,164.14
Proceeds from extraordinary items 0.00
Payment for extraordinary items 0.00
Net cash flows from (used in) financing activities 4,164.14
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 2,860.08
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 2,860.08
Cash and cash equivalents cash flow statement at beginning of period 1,263.94
Cash and cash equivalents cash flow statement at end of period 4,124.02


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Equity and liabilities
1 Shareholders' funds
Share capital 1,627.50
Reserves and surplus 22,991.70
Money received against share warrants 0.00
Total shareholders' funds 24,619.20
2 Share application money pending allotment 0.00
3 Deferred government grants 0.00
4 Minority interest 0
5 Non-current liabilities
Long-term borrowings 9,619.23
Deferred tax liabilities (net) 0.00
Foreign currency monetary item translation difference liability account 0.00
Other long-term liabilities
1 Capital Creditors 180.80
2 Security Deposits Receipt 18.40
Total of Other long-term liabilities 199.20
Long-term provisions 439.27
Total non-current liabilities 10,257.70
6 Current liabilities
Short-term borrowings 12,929.04
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 267.28
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 4,937.05
Total Trade payable 5,204.33
Other current liabilities
1 Advance received from customer 50.71
2 Audit Fees Payable 16.90
3 Income Received in Advance 77.70
4 Advance received for Sale of Land 404.00
5 Director Remuneration Payable 31.70
6 Expenses Payables 941.25
7 Interest Accrued but not due on borrowings 81.57
8 MSME Interest Payable 5.14
9 Payable to Related party 0.00
10 Salary Payable 307.10
11 Statutory Payables 331.83
Total of Other long-term liabilities 2,247.90
Short-term provisions 610.40
Total current liabilities 20,991.67
Total equity and liabilities 55,868.57
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 11,858.04
Producing properties 0.00
Intangible assets 2,299.83
Preproducing properties 0.00
Property, Plant and Equipment capital work-in-progress 1,539.67
Intangible assets under development or work-in-progress 391.00
Total Property, Plant and Equipment and Intangible assets 16,088.54
ii Non-current investments 1,667.35
v Deferred tax assets (net) 106.32
vi Foreign currency monetary item translation difference asset account 0.00
vii Long-term loans and advances 547.15
Other non-current assets
1 Security Deposits 467.76
2 Advance royalty paid 498.86
3 Fixed Deposit with Bank (Maturity for more than 12 months)* 2,086.87
Total of Other non-current assets 3,053.49
Total non-current assets 21,462.85
Current assets
Current investments 0.00
Inventories 9,495.99
Trade receivables 12,582.37
Cash and cash equivalents 4,124.00
Bank balance other than cash and cash equivalents 3,519.65
Short-term loans and advances 3,657.42
Other current assets
1 TDS Recoverable 22.30
2 TDS Receivable 3.19
3 Sale consideration receivable 1,000.00
4 HDFC BANK LOAN (802385335) 0.80
Total of Other current assets 1,026.29
Total current assets 34,405.72
Total assets 55,868.57
Disclosure of notes on assets and liabilities Textual Information(1)


Text Block

Textual Information(1)


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Sale of Product Manufactured 14,068.88 23,022.66
2 Sale of Traded Goods 5,724.89 11,150.92
Total Segment Revenue 19,793.77 34,173.58
Less: Inter segment revenue
Revenue from operations 19,793.77 34,173.58
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Sale of Product Manufactured 7,154.55 11,540.15
2 Sale of Traded Goods 2,584.95 4,418.02
Total Profit before tax 9,739.50 15,958.17
i. Finance cost 1,111.02 1,941.68
ii. Other Unallocable Expenditure net off Unallocable income 3,998.07 6,761.53
Profit before tax 4,630.41 7,254.96
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Sale of Product Manufactured 23,420.00 23,420.00
2 Sale of Traded Goods 7,384.53 7,384.53
Total Segment Asset 30,804.53 30,804.53
Un-allocable Assets 25,064.06 25,064.06
Net Segment Asset 55,868.59 55,868.59
4 Segment Liabilities
Segment Liabilities
1 Sale of Product Manufactured 3,017.74 3,017.74
2 Sale of Traded Goods 2,186.61 2,186.61
Total Segment Liabilities 5,204.35 5,204.35
Un-allocable Liabilities 50,664.24 50,664.24
Net Segment Liabilities 55,868.59 55,868.59
Disclosure of notes on segments




Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 R K Jagetiya & Co. Yes 30-06-2027